Somatic Loss of the Y Chromosome and Alzheimer's Disease Risk
Palmer, E. L.; Benchek, P.; Wheeler, N. R.; Smeiszek, S.; Naj, A. C.; Haines, J. L.; Pericak-Vance, M. A.; Forsberg, L. A.; Cukier, H. N.; Song, Y.; Bush, W.
Show abstract
Mosaic loss of the Y chromosome (LOY) is a somatic, age-related event that has been previously associated with a variety of diseases of aging. A prior study of European cohorts demonstrated an association between LOY and Alzheimers Disease and more recent molecular studies have shown that LOY can also occur within microglia, suggesting a potential functional role in AD pathogenesis. In this study, we further validate the association between LOY and AD via prospective analyses of 1,447 males, and perform Mendelian Randomization analysis on 10,013 males across 26 US cohorts. Significant results from these analyses provide further evidence for a role of LOY in the development of Alzheimers Disease.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease 95%
- Association between telomere length and cognitive function among cognitively unimpaired individuals at risk of Alzheimer’s disease 94%
- Explainable artificial intelligence identifies an AQP4 polymorphism-based risk score associated with brain amyloid burden 93%
Similar papers in this journal
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer’s disease diagnosis in a case-control analysis 98%
- Inferring Alzheimer’s disease pathologic traits from clinical measures in living adults 96%
- Alzheimer’s Disease variant portal (ADVP): a catalog of genetic findings for Alzheimer’s Disease 96%
Similar papers in this journal
Similar papers in this journal
- Brain and Blood Transcriptome-Wide Association Studies Identify Five Novel Genes Associated with Alzheimer’s Disease 98%
- Frequency of Variants in Mendelian Alzheimer’s Disease Genes within the Alzheimer’s Disease Sequencing Project (ADSP) 96%
- Exploring the genetic heterogeneity of Alzheimer’s disease: Evidence for genetic subtypes 96%